About BOT
Botanix Pharmaceuticals (BOT), based in Philadelphia and Phoenix, is a dermatology-focused drugmaker whose FDA-approved product Sofdra treats primary axillary hyperhidrosis — the first new chemical entity cleared by the FDA for that condition and a long-awaited option for patients with this disruptive disorder.
All News for BOT
No news articles found for BOT yet.